The Point-of-Care (POC) Coagulation Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Point-of-Care (POC) Coagulation Testing Market:
According to The Business Research Company’s Point-of-Care (POC) Coagulation Testing Global Market Report 2024, The point-of-care (POC) coagulation testing market size is expected to see steady growth in the next few years. It will grow to $1.42 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to expanding applications in healthcare, rising demand in homecare settings, increased prevalence of chronic blood disorders, patient demand for rapid and accurate testing, rise in point-of-care testing. Major trends in the forecast period include technological advancements, high demand in developed countries, expanding applications in healthcare, COVID-19 impact, multiplexing POC diagnostics.
The rising incidence of cardiovascular diseases is expected to propel the growth of the point-of-care (POC) coagulation testing market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders of the heart and blood vessels, including conditions such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing is helpful in the treatment of cardiovascular diseases (CVDs) as it provides real-time information on coagulation status, enabling timely decision-making on coagulation interventions and reducing the risk of bleeding complications after cardiac surgery. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in the United States, heart disease claimed the lives of about 695,000 people in 2021, accounting for 1 in 5 fatalities. Further, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Therefore, the rising incidence of cardiovascular diseases is driving the growth of the point-of-care (POC) coagulation testing market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp
The point-of-care (poc) coagulation testing market covered in this report is segmented –
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care
Major companies operating in the point-of-care (POC) coagulation testing market are focused on strategic collaborations to gain a competitive edge in the market. Strategic collaboration is a formal agreement between two or more parties to work together toward achieving specific, predetermined goals that are mutually beneficial. For instance, in October 2021, Trivitron Healthcare, an Indian-based medical devices company, collaborated with Diagon Ltd., a US-based manufacturer of IVD products, and Vanguard Diagnostics, an Indian-based manufacturer of diagnostic products, to launch Coagulation Analyzer products. It provides accurate and efficient coagulation testing, and the collaboration aims to improve patient diagnosis and management. The diverse range of analyzers caters to various healthcare settings, making coagulation testing more accessible.
The point-of-care (poc) coagulation testing market report table of contents includes:
- Executive Summary
- Point-of-Care (POC) Coagulation Testing Market Characteristics
- Point-of-Care (POC) Coagulation Testing Market Trends And Strategies
- Point-of-Care (POC) Coagulation Testing Market - Macro Economic Scenario
- Global Point-of-Care (POC) Coagulation Testing Market Size and Growth
.
.
.
- Global Point-of-Care (POC) Coagulation Testing Market Competitive Benchmarking
- Global Point-of-Care (POC) Coagulation Testing Market Competitive Dashboard
- Key Mergers And Acquisitions In Point-of-Care (POC) Coagulation Testing Market
- Point-of-Care (POC) Coagulation Testing Market Future Outlook and Potential Analysis
- Appendix
Top Major Players :
- AT&T Corporation
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Hoffmann-La Roche Ltd
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
A health care professional or a nurse performs the test, analysis is performed, and lastly the results are recorded.
Tests include lateral flow immunochromatography, enzyme-linked immunosorbent assays (ELISA), and agglutination test.Strong expertise with attention to detail makes our market research reports stand apart, Request a Report sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=25535 The health care industry has witnessed a major change in the past few years due to emerging technological innovations including biosensors, lab-on-a-chip, smartphone apps, and other wearable devices, contributing to a closer connection with the patient- point-of care technologies due to which it is becoming a part of the transformational healthcare landscape.
Increase in geriatric population, rise in prevalence of cardiovascular and diabetic diseases, and increased health care awareness are the major drivers of the market.
Improved technology, lab automation to provide cheaper, accurate, and high quality results, and increased home care facilities with rapid and effective diagnostic results also contribute to the growth of the point-of care lipid testing market.
Rural locations with limited lab services and shortage of trained laboratory workers present an opportunity for new entrants in developing countries.Pre Book Point of Care (POC) Lipid Testing Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=25535=SBased on product type, the POC lipid testing market has been segmented into consumables and instruments.
In terms of application, the market has been segmented into hypertriglyceridemia, hyperlipoproteinemia, Tangier disease, hyperlipidemia, familial hypercholesterolemia, and others.
Global Point-of-Care Testing Market (POC) was valued US$ 14Bn in 2017 and is anticipated to reach US$ 30Bn by 2026 at a CAGR of about 10.0% during a forecast.
Based on product type point of care market is segmented into Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Haematology Testing, Blood Gas Testing & Others.
By End-User are segmented in Clinics, Home, Laboratories, Assisted living healthcare facilities, Hospitals.
Geographically into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.The driving factor for the point of care market is due to Rising in usage of home-based glucose monitoring systems, Coagulation Monitoring, Infectious Diseases Testing, in trending Pregnancy And Fertility Testing, developing technology and innovative launching scheme and best offers to eventually reduce public and national spending on health, These devices are being highly used for the rapid diagnosis of disease conditions for the early detection and management of the disease are the factor of growth in point of care market.
High logistics costs and huge investment will be the restrains for point of care market.Global Point-of-Care (POC) Testing Market is segmented into by product, by Product Type, by End-user Type, and by geography.
In End, User segment Home Care will be fastest growing department due to Growing concern for early-stage disease detection and to avoid the occurrence of any chronic condition is expected to drive the remote monitoring and raise demand for rapid tests are a growth opportunity in the point-of-care testing market.For More Information Visit https://www.maximizemarketresearch.com/market-report/global-point-of-care-testing-market/15349/Among region, Asia Pacific is expected to grow at the highest CAGR during the forecast period.
